|
2017
|
Invention
|
Controlled dose drug delivery system.
A multiple pulsed dose drug delivery system for pharmaceut... |
|
|
P/S
|
Providing an interactive website featuring technology allowing users to construct a representatio... |
|
2014
|
Invention
|
Fixed dose combination treatment for schizophrenia. The present invention relates to a fixed dosa... |
|
|
Invention
|
Capsule and powder formulations containing lanthanum compounds.
The present invention includes a... |
|
2011
|
Invention
|
Abuse-resistant amphetamine prodrugs.
The invention describes compounds, compositions, and metho... |
|
|
Invention
|
Process for the synthesis of prodrugs of opioids.
The present invention provides a process for t... |
|
|
Invention
|
Meptazinol carbamate prodrug salts.
The present invention relates to salts of meptazinol carbama... |
|
|
Invention
|
Mexiletine prodrugs. The present invention concerns prodrugs of mexiletine (and mexiletine's acti... |
|
|
Invention
|
Capsule and powder formulations containing lanthanum compounds. The present invention includes an... |
|
|
Invention
|
Oil based formulations. The present invention relates to the use of oil based delivery vehicles t... |
|
|
Invention
|
Combination treatment of major depressive disorder.
A method is provided for treating depression... |
|
|
Invention
|
Combination treatment of major depressive disorder. A method is provided for treating depression,... |
|
|
Invention
|
Process for the preparation of anagrelide and analogues thereof. The present invention relates to... |
|
|
Invention
|
Use of prodrugs to avoid gi mediated adverse events. The present invention relates to prodrugs of... |
|
|
Invention
|
Prodrugs of guanfacine. Prodrugs of guanfacine, pharmaceutical compositions containing such prodr... |
|
|
Invention
|
Prodrugs of guanfacine.
Prodrugs of guanfacine, pharmaceutical compositions containing such prod... |
|
|
Invention
|
Homoarginine prodrugs and/or conjugates of amphetamine and other stimulants and processes for mak... |
|
|
Invention
|
Combination therapy with lisdexamphetamine and extended release guanfacine.
The present inventio... |
|
|
Invention
|
Combination therapy with lisdexamphetamine and extended release guanfacine. The present invention... |
|
|
Invention
|
Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents. Di... |
|
|
Invention
|
Anagrelide derivatives (imidazo [2, 1-b] quinazolin - 2 - ones ) as pde iii inhibitors useful as ... |
|
|
Invention
|
Substituted quinazolines (open ring). This invention relates to the discovery of prodrugs of 5-su... |
|
|
Invention
|
Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using... |
|
2010
|
Invention
|
Prodrugs of opioids and uses thereof. The present invention concerns prodrugs of opioid analgesic... |
|
|
Invention
|
Capsule formulations containing lanthanum compounds. The present invention includes an oral pharm... |
|
|
Invention
|
Prodrugs of guanfacine.
Prodrugs of guanfacine with amino acids or short peptides, pharmaceutica... |
|
|
Invention
|
Prodrugs of guanfacine. Prodrugs of guanfacine with amino acids or short peptides,pharmaceutical ... |
|
|
Invention
|
Galantamine amino acid and peptide prodrugs and uses thereof.
Prodrugs of galantamine or its 3-h... |
|
|
Invention
|
Novel carbamate amino acid and peptide prodrugs of opiates and uses thereof.
Carbamate linked pr... |
|
|
Invention
|
Mono and di-substituted oxycodone compounds and compositions.
The invention relates to pharmaceu... |
|
2009
|
Invention
|
Process for the preparation of anagrelide and analogues. The present invention relates to a novel... |
|
|
Invention
|
Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents.
... |
|
|
Invention
|
Substituted quinazolines.
This invention relates to the discovery of prodrugs of substituted ana... |
|
|
Invention
|
Substituted quinazolines as blood platelet lowering agents.
This invention relates to the discov... |
|
|
Invention
|
Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases.
This inventi... |
|
|
Invention
|
2h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative ag... |
|
|
Invention
|
Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific disease... |
|
|
Invention
|
Substituted quinazolines.
This invention relates to the discovery of substituted analogues of th... |
|
|
Invention
|
Substituted quinazolines.
This invention relates to the discovery of 3-and 5-substituted analogu... |
|
2007
|
Invention
|
Antidepressant prodrugs.
The invention provides antidepressant prodrugs comprising an antidepres... |
